You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: June 2022 to February 2026

AbstractFullPdf
Jun 2022632645373
Jul 2022486503252
Aug 2022294299115
Sep 2022396410150
Oct 2022308315106
Nov 202221521983
Dec 202218618790
Jan 202318418993
Feb 2023213220145
Mar 2023190191102
Apr 202312612988
May 202315415781
Jun 202316316878
Jul 202312312676
Aug 202327827965
Sep 2023828344
Oct 202312812863
Nov 202333533577
Dec 2023140140107
Jan 2024889177
Feb 202411611769
Mar 2024292296142
Apr 202413814084
May 202413313490
Jun 202412412379
Jul 202414714897
Aug 202410110182
Sep 202411611685
Oct 202411111270
Nov 2024135137129
Dec 2024205208132
Jan 2025136136112
Feb 2025244244125
Mar 2025163163140
Apr 2025188188136
May 2025220221106
Jun 20259810157
Jul 2025110
Sep 2025110
Feb 2026110
Total739175024000